Sort
39,280 grants matching “leukemia”
Developing CRM1 inhibitors in AML
$319,550Ramiro Garzon · Ohio State University · R01 · FY2015 · CA
Pathogenetic Mechanism and Clinical Targeting of CSF3R-Driven Cancer
$319,550Jeffrey Wallace Tyner · Oregon Health & Science University · R01 · FY2015 · CA
Developing CRM1 inhibitors in AML
$319,550Ramiro Garzon · Ohio State University · R01 · FY2016 · CA
Pathogenetic Mechanism and Clinical Targeting of CSF3R-Driven Cancer
$319,550Jeffrey Wallace Tyner · Oregon Health & Science University · R01 · FY2017 · CA
Dual targeting of XPO1 and BTK in B cell malignancies
$319,550Rosa Lapalombella · Ohio State University · R01 · FY2015 · CA
Small Molecule Inhibitors for the Oncogenic Protein Tyrosine Phosphatase SHP2
$319,550Zhong-Yin Zhang · Indiana University Indianapolis · R01 · FY2010 · CA
Pathogenetic Mechanism and Clinical Targeting of CSF3R-Driven Cancer
$319,550Jeffrey Wallace Tyner · Oregon Health & Science University · R01 · FY2018 · CA
Developing CRM1 inhibitors in AML
$319,550Ramiro Garzon · Ohio State University · R01 · FY2018 · CA
HES1 mediates cell-specific consequences of Notch signaling in ALL
$319,550Patrick A Zweidler-McKay · University Of Tx Md Anderson Can Ctr · R01 · FY2010 · CA
Investigating the role of p73 and its isoforms in tumorigenesis and metastasis
$319,550Elsa R Flores · University Of Tx Md Anderson Can Ctr · R01 · FY2009 · CA
Epigenetic tumor induction by heterochromatin instability
$319,550Willis X Li · University Of Rochester · R01 · FY2009 · CA
Genetic Manipulation of T Cells--PreClinical Models
$319,550Washington University · R01 · FY2005 · CA
Novel monocyte effector function in CLL immune therapy
$319,550Susheela Tridandapani · Ohio State University · R01 · FY2017 · CA
Role of Shp2 in FLT3-ITD-Induced Leukemogenesis
$319,550Rebecca J Chan · Indiana University Indianapolis · R01 · FY2011 · CA
Role of Shp2 in FLT3-ITD-Induced Leukemogenesis
$319,550Rebecca J Chan · Indiana University Indianapolis · R01 · FY2015 · CA
Genetic Manipulation of T Cells--PreClinical Models
$319,550Washington University · R01 · FY2004 · CA
Genetic Manipulation of T Cells--PreClinical Models
$319,550Washington University · R01 · FY2003 · CA
Transdisciplinary Collaboration and Coordination
$319,535Richard James Gilbertson · St. Jude Children'S Research Hospital · P30 · FY2017 · CA
Transdisciplinary Collaboration and Coordination
$319,532Richard James Gilbertson · St. Jude Children'S Research Hospital · P30 · FY2018 · CA
Harnessing Alloreactivity
$319,530Fuchs Ephraim · Johns Hopkins University · P01 · FY2007 · CA
Genetic Analysis of Polarity
$319,511Ruth M Steward · Rutgers, The State Univ Of N.J. · R56 · FY2008 · HD
Recombinant AAV Gene Therapy Vector Recombination, Integration, and Genotoxicity
$319,500Douglas M McCarty · Research Inst Nationwide Children'S Hosp · R01 · FY2006 · AI
Project 1: Biomarkers of Chemical Exposure and Leukemia Risk
$319,483Martyn T Smith · University Of California Berkeley · P42 · FY2011 · ES
Identifying Cell Stress Proteins that Predict Clinical Response in Pediatric AML
$319,474Terzah M Horton · Baylor College Of Medicine · R01 · FY2017 · CA
Dartmouth Lead Participation in NCI National Clinical Trials Network
$319,472Konstantin H. Dragnev · Dartmouth College · U10 · FY2015 · CA